PIK3CA Mutation: A Key to Improved Colon Cancer Outcomes
A recent clinical trial, CALGB/SWOG 80702 (Alliance), has shed light on a potential new treatment strategy for patients with stage III colon cancer and a specific genetic mutation....
Read →healthHQ articles
Latest Health news and analysis from healthHQ.